NEW YORK (GenomeWeb News) – Laboratory Corporation of America today reported fourth quarter revenue growth of around 2 percent, but it fell short of Wall Street estimates on the top and bottom line.

The clinical lab giant reported total revenues of $1.44 billion for the three months ended Dec. 31, up from $1.41 billion for the fourth quarter of 2012 but below the average analyst estimate of $1.45 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.